Challenges and Considerations in SP Procurement for PMI
Challenges and considerations in the procurement of Sulfadoxine-Pyrimethamine (SP) for the U.S. President's Malaria Initiative (PMI), including eligibility criteria, country procurers, formulation options, support to manufacturers, and regulatory requirements. The content highlights the shift towards partner government procurement, support strategies when PMI is not procuring, and the importance of regulatory and pharmaceutical systems strengthening.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
PMIs PROCUREMENT OF SULFADOXINE-PYRIMETHAMINE (SP) RBM MIP Working Group, September 12, 2023 U.S. PRESIDENT S MALARIA INITIATIVE 1
PMI SP Procurement: Challenges and Considerations Eligibility for PMI procurement: PMI-procured SP requires a restricted commodity approval from USAID prior to procurement. To obtain approval, PMI commodities should be at least one of the following: WHO Pre-Qualified Stringent Regulatory Authority (SRA) Approved Procured through a USAID approved wholesaler Country registration often required. Presentations procured: Movement away from blister pack presentations towards 100 and 1000 tablet bottles Formulation: dispersible vs. non-dispersible Support to manufacturing in sub-Saharan Africa Support to manufacturers to attain approval Challenges: domestic market, cost implications, time to achieve WHO PQ and cost, etc. U.S. PRESIDENT S MALARIA INITIATIVE 2
SP Procurement in PMI Countries Country Procurer Country Procurer Country Procurer Angola PMI; Government Guinea GF Nigeria Government Benin PMI; GF; Government Kenya Government Senegal GF; Government Burkina Faso Liberia Sierra Leone Government PMI GF Burundi GF; PMI Madagascar PMI; GF Tanzania Government Cameroon PMI; GF Malawi PMI Uganda Government Mali Zambia Government; PMI; GF GF; Government PMI Cote d Ivoire DRC PMI Mozambique Government Zimbabwe PMI; GF Ghana PMI; Government Niger PMI; GF U.S. PRESIDENT S MALARIA INITIATIVE 3
General SP Procurement: Challenges and Considerations Shift to partner government procurement: positive in terms of sustainability, but accompanied by a variety of challenges When PMI is not procuring, we support in other ways to ensure quality-assured SP is purchased: Support to governments to ensure procurements take place (both on-time and in appropriate quantities) Visibility of relevant stakeholders of those orders Support to manufacturers to ensure that there are viable options Regulatory and pharmaceutical systems strengthening U.S. PRESIDENT S MALARIA INITIATIVE 4
THANK YOU. U.S. PRESIDENT S MALARIA INITIATIVE 5
